Quizartinib for frontline FLT3-ITD+ AML: updated results from the QuANTUM-First trial VJHemOnc – Video Journal of Hematology & HemOnc 2:35 1 year ago 534 Далее Скачать
Dr. Levis on the Background and Future of Quizartinib for AML Targeted Oncology 1:37 11 years ago 131 Далее Скачать
Quizartinib advances overall survival in acute myeloid leukaemia patients ecancer 3:35 2 years ago 190 Далее Скачать
Potential approval of quizartinib in AML & its place in the AML treatment regimen VJHemOnc – Video Journal of Hematology & HemOnc 0:57 1 year ago 259 Далее Скачать
Dr. Levis on the Ideal Way to Use Quizartinib to Treat AML Targeted Oncology 1:28 10 years ago 184 Далее Скачать
Dr. Levis Discusses the Ideal Use of Quizartinib in FLT3-ITD AML OncLive 1:18 10 years ago 451 Далее Скачать
Progress for gilteritinib and quizartinib for AML in the first-line setting VJHemOnc – Video Journal of Hematology & HemOnc 1:50 6 years ago 308 Далее Скачать
Tangible benefit for FLT3-ITD R/R AML on quizartinib VJHemOnc – Video Journal of Hematology & HemOnc 1:59 5 years ago 193 Далее Скачать
Azacitidine + quizartinib for patients with MDS and MPNs with FLT3 or CBL mutation VJHemOnc – Video Journal of Hematology & HemOnc 4:44 2 years ago 70 Далее Скачать
Preclinical data for quizartinib plus MDM2 inhibitor in AML VJHemOnc – Video Journal of Hematology & HemOnc 3:03 6 years ago 173 Далее Скачать
Results of QuANTUM-First: quizartinib vs placebo plus intensive chemotherapy in FLT3-ITD+ AML VJHemOnc – Video Journal of Hematology & HemOnc 4:32 2 years ago 325 Далее Скачать
Safety by treatment phase and age when treating FLT3-ITD-mutated AML with quizartinib and chemo VJHemOnc – Video Journal of Hematology & HemOnc 5:24 10 months ago 71 Далее Скачать
